Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

MGNX - Macrogenics Inc


IEX Last Trade
3.52
0.050   1.420%

Share volume: 1,276,805
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$3.47
0.05
1.44%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-08 2022-11-03 2023-03-15 2023-05-09 2023-08-09 2023-11-06 2024-03-07 2024-05-09
Total revenue 26.007 M 41.734 M 73.099 M 24.496 M 13.136 M 10.397 M 10.720 M 9.104 M
Cost of revenue 2.402 M 3.143 M 1.791 M 3.523 M 1.177 M 3.359 M 163.000 K 2.116 M
Gross profit 23.605 M 38.591 M 71.308 M 20.973 M 11.959 M 7.038 M 10.557 M 6.988 M
    63.49% 84.78% -70.59% -42.98% -41.15% 50.00% -33.81%  
Operating expenses 65.413 M 63.546 M 59.325 M 59.399 M 56.921 M 42.540 M 59.911 M 60.738 M
Selling general and admin 13.669 M 15.355 M 13.672 M 13.527 M 13.692 M 12.409 M 12.560 M 14.709 M
Research and development 51.744 M 48.191 M 45.653 M 45.872 M 43.229 M 30.131 M 47.351 M 46.029 M
Total expenses 67.815 M 66.689 M 61.116 M 62.922 M 58.098 M 45.899 M 60.074 M 62.854 M
    -1.66% -8.36% 2.96% -7.67% -21.00% 30.88% 4.63%  
Operating income -41.808 M -24.955 M 11.983 M -38.426 M -44.962 M -35.502 M -49.354 M -53.750 M
Ebit -41.808 M -24.955 M 11.983 M -38.426 M -44.962 M -35.502 M -49.354 M -53.750 M
Pretax income -41.304 M -24.813 M 12.802 M -38.009 M 57.469 M 17.554 M -46.072 M -52.190 M
    -39.93% -151.59% -396.90% -251.20% -69.45% -362.46% 13.28%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -41.304 M -24.813 M 12.802 M -38.009 M 57.469 M 17.554 M -46.072 M -52.190 M
    39.93% 151.59% -396.90% 251.20% -69.45% -362.46% -13.28%  
Net income -41.304 M -24.813 M 12.802 M -38.009 M 57.469 M 17.554 M -46.072 M -52.190 M
    39.93% 151.59% -396.90% 251.20% -69.45% -362.46% -13.28%